寰宇娛樂文化(01046.HK)料截至6月底止年度虧損淨額按年大減
寰宇娛樂文化(01046.HK)公布,集團正在編製其截至6月底之全年業績,根據現有可得資料,董事會獲悉預期集團於本年度之收益將較對上一年同期大幅增加,而期內虧損淨額將按年大幅減少,主要因為2019年下半年集團在內地上映名為「掃毒2天地對決」,並在中國錄得13億元人民幣(下同)票房,而今年上半年集團收益及業績受到持續爆發新型冠狀病毒之負面影響,集團相信於短中期內,高失業率、消費疲弱及全球第二波新型冠狀病毒疫情的威脅將繼續削弱全球經濟,集團預期於本年度錄得之電影版權及相關訂金減值虧損會有所增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.